# First-of-its-Kind Medical Cannabis Education Platform for Clinicians and Patients Now Open > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medical-cannabis-education-platform-clinicians-patients/ > **Published:** 2026-04-21T18:05:18-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:15:52-04:00 > **Clinical Summary:** Explore the new medical cannabis education platform designed to enhance clinician and patient knowledge in cannabis medicine and clinical training. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Medical EducationClinical TrainingEvidence-Based PracticeProfessional Development[Cannabis Medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) Why This Matters Educational gaps remain the primary barrier to effective [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) implementation, with most clinicians receiving no formal training despite growing patient demand. Structured educational platforms could standardize knowledge and improve clinical outcomes by addressing the evidence-practice disconnect. Clinical Summary A new [medical cannabis education](https://cedclinic.com/endocannabinoid-system-sleep-wake-cycle-dream-modulation/) platform has launched targeting both clinicians and patients, representing an attempt to address widespread knowledge gaps in cannabis medicine. The platform appears designed to provide structured educational content, though specific curriculum details, evidence basis, and clinical validation metrics are not specified in available information. Educational initiatives like this emerge as healthcare systems struggle with the disconnect between patient access to cannabis and clinician preparedness to guide its medical use. Dr. Caplan’s Take “Education is essential, but I’m always cautious about platforms that don’t clearly specify their evidence standards or clinical methodology. The real test is whether they’re teaching what we actually know versus what sounds compelling.” Clinical Perspective 🧠 Clinicians should evaluate any [cannabis education](https://cedclinic.com/unlock-healing-potential-cannabis-audiobook/) platform for evidence-based content, peer review processes, and clear delineation between established clinical data and emerging research. Look for programs that emphasize mechanism uncertainty, drug interactions, and individualized dosing approaches rather than broad therapeutic claims. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20First-of-its-Kind%20Medical%20Cannabis%20Education%20Platform%20for%20Clinicians%20and%20Patient...%20%40drcaplan&url=https%3A//finance.yahoo.com/sectors/healthcare/articles/first-kind-medical-cannabis-education-120000117.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//finance.yahoo.com/sectors/healthcare/articles/first-kind-medical-cannabis-education-120000117.html)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20First-of-its-Kind%20Medical%20Cannabis%20Education%20Platform%20for%20Clinicians%20and%20Patient...%20--%20via%20%40drcaplan.bsky.social%20https%3A//finance.yahoo.com/sectors/healthcare/articles/first-kind-medical-cannabis-education-120000117.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://finance.yahoo.com/sectors/healthcare/articles/first-kind-medical-cannabis-education-120000117.html](https://finance.yahoo.com/sectors/healthcare/articles/first-kind-medical-cannabis-education-120000117.html) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What type of medical education content does this relate to?](#What_type_of_medical_education_content_does_this_relate_to) - [Who is the target audience for this clinical information?](#Who_is_the_target_audience_for_this_clinical_information) - [Why is this classified as “Notable Clinical Interest”?](#Why_is_this_classified_as_8220Notable_Clinical_Interest8221) - [What should healthcare professionals expect from this type of content?](#What_should_healthcare_professionals_expect_from_this_type_of_content) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance rating system appears to be a classification method that assigns numerical ratings to clinical content based on its importance and relevance to healthcare practice. Rating #76 indicates “Notable Clinical Interest” for emerging findings or policy developments that merit close monitoring by medical professionals. #### What type of medical education content does this relate to? This content focuses on cannabis-related medical education and clinical training. It encompasses evidence-based practice guidelines and professional development resources for healthcare providers working with cannabis therapeutics. #### Who is the target audience for this clinical information? The primary audience includes healthcare professionals, medical educators, and clinicians seeking to enhance their knowledge and skills in cannabis medicine. This content is designed for those involved in evidence-based practice and professional development in this emerging field. #### Why is this classified as “Notable Clinical Interest”? The classification indicates that this cannabis-related content represents emerging findings or policy developments in the medical field. These developments are considered significant enough to warrant close monitoring by healthcare professionals staying current with evolving cannabis medicine practices. #### What should healthcare professionals expect from this type of content? Healthcare professionals can expect educational material focused on [evidence-based cannabis](https://cedclinic.com/jama-cannabis-review-physician-analysis/) medicine practices and clinical training resources. The content aims to support professional development and provide clinically relevant information for practitioners in this rapidly evolving field. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [New medical cannabis education platform for clinicians and patients now open – MMJDaily](https://cedclinic.com/new-medical-cannabis-education-platform/) Learn about the launch of a new education platform aimed at improving cannabis knowledge for clinicians and patients. [Read More](https://cedclinic.com/new-medical-cannabis-education-platform/) [Whether you're new to medical cannabis or continuing your patient journey, staying …](https://cedclinic.com/medical-cannabis-patient-journey-support/) Explore resources and guidance for patients at all stages of their [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) journey. [Explore Now](https://cedclinic.com/medical-cannabis-patient-journey-support/) Navigating Cannabis and Cannabinoid Use in Today's Clinical Practice – YouTube Watch expert discussions on integrating cannabis therapeutics into modern clinical practice. Watch Video ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).